Zyprexa heart attack

Case studies and clinical trials have not produced any evidence that would indicate that Zyprexa heart attack risks are significantly increased in patients taking this antipsychotic medication. For patients with a history of heart and other health conditions, however, it is important to speak to a doctor about Zyprexa heart attack risks. For this patient population, Zyprexa heart attack risks may contraindicate the use of this atypical antipsychotic medication.

Patients with a history of heart attack, heart disease, high blood pressure, seizures, and other medical conditions may wish to discuss their full medical history and Zyprexa heart attack risks with their health care providers prior to commencing any treatment. A doctor may determine that the risk of a Zyprexa heart attack outweighs the intended benefits of this medication, or s/he may decide that careful monitoring of a patient's condition is sufficient.

Zyprexa is an atypical anti-psychotic medication that is used to treat the unfavorable symptoms associated with schizophrenia and bipolar disorder. This drug was first approved by the FDA in 1996. Soon after Zyprexa gained federal approval, several studies indicated serious and deadly side effects associated with this drug.

The most serious side effect associated with Zyprexa is diabetes and related complications. A government whistleblower claims that the FDA knew of these serious risks before Zyprexa was approved for use in the United States. One comprehensive report indicates that the government had access to pre-marketing clinical trial information that should have provoked more serious concerns about Zyprexa safety.

In 2002, Duke University reported the striking results of their Zyprexa research. Duke researchers discovered nearly three hundred cases of Zyprexa patients who developed treatment-emergent diabetes soon after commencing treatment. One hundred of these victims also suffered ketoacidosis, a fatal diabetes complication. Twenty three of the subjects in the study died as a result of Zyprexa side effects.

Zyprexa heart attack and diabetes risks have been known for years, yet Eli Lilly (the makers of this drug) have yet to take the steps necessary to protect consumers from these risks. Drug companies have a legal duty to inform consumers about the risks associated with their products. When serious risks, like Zyprexa heart attack and diabetes risks, are posed, a drug company may have a duty to act to protect consumers from these dangers.